Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.
Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L. Kaufmann M, et al. Among authors: ruckhaeberle e. Ann Surg Oncol. 2012 May;19(5):1508-16. doi: 10.1245/s10434-011-2108-2. Epub 2011 Dec 23. Ann Surg Oncol. 2012. PMID: 22193884
Clinical relevance of the putative stem cell marker p63 in breast cancer.
Hanker L, Karn T, Ruckhaeberle E, Gaetje R, Solbach C, Schmidt M, Engels K, Holtrich U, Kaufmann M, Rody A. Hanker L, et al. Among authors: ruckhaeberle e. Breast Cancer Res Treat. 2010 Aug;122(3):765-75. doi: 10.1007/s10549-009-0608-6. Epub 2009 Nov 7. Breast Cancer Res Treat. 2010. PMID: 19898932
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial.
Kaufmann M, Maass N, Costa SD, Schneeweiss A, Loibl S, Sütterlin MW, Schrader I, Gerber B, Bauer W, Wiest W, Tomé O, Distelrath A, Hagen V, Kleine-Tebbe A, Ruckhaeberle E, Mehta K, von Minckwitz G; GBG-39 Trialists. Kaufmann M, et al. Among authors: ruckhaeberle e. Eur J Cancer. 2010 Dec;46(18):3184-91. doi: 10.1016/j.ejca.2010.07.009. Epub 2010 Aug 24. Eur J Cancer. 2010. PMID: 20797843 Clinical Trial.
A clinically relevant gene signature in triple negative and basal-like breast cancer.
Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, Hanker L, Gaetje R, Solbach C, Ahr A, Metzler D, Schmidt M, Müller V, Holtrich U, Kaufmann M. Rody A, et al. Among authors: ruckhaeberle e. Breast Cancer Res. 2011 Oct 6;13(5):R97. doi: 10.1186/bcr3035. Breast Cancer Res. 2011. PMID: 21978456 Free PMC article.
Recent advances in radiotherapy of breast cancer.
Haussmann J, Corradini S, Nestle-Kraemling C, Bölke E, Njanang FJD, Tamaskovics B, Orth K, Ruckhaeberle E, Fehm T, Mohrmann S, Simiantonakis I, Budach W, Matuschek C. Haussmann J, et al. Among authors: ruckhaeberle e. Radiat Oncol. 2020 Mar 30;15(1):71. doi: 10.1186/s13014-020-01501-x. Radiat Oncol. 2020. PMID: 32228654 Free PMC article. Review.
Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients.
Matuschek C, Nestle-Kraemling C, Haussmann J, Bölke E, Wollandt S, Speer V, Djiepmo Njanang FJ, Tamaskovics B, Gerber PA, Orth K, Ruckhaeberle E, Fehm T, Corradini S, Lammering G, Mohrmann S, Audretsch W, Roth S, Kammers K, Budach W. Matuschek C, et al. Among authors: ruckhaeberle e. Strahlenther Onkol. 2019 Jul;195(7):615-628. doi: 10.1007/s00066-019-01473-2. Epub 2019 May 17. Strahlenther Onkol. 2019. PMID: 31101954 English.
19 results